Voyager Therapeutics Inc (NASDAQ: VYGR) kicked off on Tuesday, down -5.23% from the previous trading day, before settling in for the closing price of $4.21. Over the past 52 weeks, VYGR has traded in a range of $2.64-$6.27.
Annual sales at Healthcare sector company grew by 1.48% over the past five years. While this was happening, its average annual earnings per share was recorded -85.01%. With a float of $45.82 million, this company’s outstanding shares have now reached $55.48 million.
Let’s look at the performance matrix of the company that is accounted for 172 employees.
Voyager Therapeutics Inc (VYGR) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Voyager Therapeutics Inc is 17.59%, while institutional ownership is 54.70%. The most recent insider transaction that took place on Oct 03 ’25, was worth 36,643. In this transaction Chief Financial Officer of this company sold 7,666 shares at a rate of $4.78, taking the stock ownership to the 123,834 shares. Before that another transaction happened on Oct 03 ’25, when Company’s Officer proposed sale 5,843 for $4.78, making the entire transaction worth $27,937.
Voyager Therapeutics Inc (VYGR) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.59 earnings per share (EPS), lower than consensus estimate (set at -0.35) by -0.24. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.49 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -85.01% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -9.77% during the next five years compared to 1.48% growth over the previous five years of trading.
Voyager Therapeutics Inc (NASDAQ: VYGR) Trading Performance Indicators
Take a look at Voyager Therapeutics Inc’s (VYGR) current performance indicators. Last quarter, stock had a quick ratio of 6.19. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.17, a number that is poised to hit -0.51 in the next quarter and is forecasted to reach -1.60 in one year’s time.
Technical Analysis of Voyager Therapeutics Inc (VYGR)
Voyager Therapeutics Inc (NASDAQ: VYGR) saw its 5-day average volume 0.5 million, a negative change from its year-to-date volume of 0.56 million. As of the previous 9 days, the stock’s Stochastic %D was 18.15%.
During the past 100 days, Voyager Therapeutics Inc’s (VYGR) raw stochastic average was set at 41.49%, which indicates a significant increase from 7.81% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.22 in the past 14 days, which was lower than the 0.28 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.38, while its 200-day Moving Average is $3.76. Nevertheless, the first resistance level for the watch stands at $4.12 in the near term. At $4.24, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.33. If the price goes on to break the first support level at $3.91, it is likely to go to the next support level at $3.82. The third support level lies at $3.70 if the price breaches the second support level.
Voyager Therapeutics Inc (NASDAQ: VYGR) Key Stats
The company with the Market Capitalisation of 221.84 million has total of 55,600K Shares Outstanding. Its annual sales at the moment are 80,000 K in contrast with the sum of -65,000 K annual income. Company’s last quarter sales were recorded 13,370 K and last quarter income was -27,890 K.
